受强制性开放获取政策约束的文章 - Constantia Pantelidou了解详情
可在其他位置公开访问的文章：8 篇
PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer
C Pantelidou, O Sonzogni, M De Oliveria Taveira, AK Mehta, A Kothari, ...
Cancer discovery 9 (6), 722-737, 2019
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors
J Zhou, C Gelot, C Pantelidou, A Li, H Yücel, RE Davis, A Färkkilä, ...
Nature cancer 2 (6), 598-610, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health, European …
EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
KL Morel, AV Sheahan, DL Burkhart, SC Baca, N Boufaied, Y Liu, X Qiu, ...
Nature cancer 2 (4), 444-456, 2021
强制性开放获取政策： US National Institutes of Health, Fonds de recherche du Québec - Santé
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
AK Mehta, EM Cheney, CA Hartl, C Pantelidou, M Oliwa, JA Castrillon, ...
Nature cancer 2 (1), 66-82, 2021
强制性开放获取政策： US National Institutes of Health, Government of Spain, Susan G. Komen
The novel oncolytic adenoviral mutant Ad5-3Δ-A20T retargeted to αvβ6 integrins efficiently eliminates pancreatic cancer cells
YKS Man, JA Davies, L Coughlan, C Pantelidou, A Blázquez-Moreno, ...
Molecular cancer therapeutics 17 (2), 575-587, 2018
强制性开放获取政策： Cancer Research UK, Pancreatic Cancer, UK
The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11
C Pantelidou, G Cherubini, NR Lemoine, G Halldén
Oncotarget 7 (13), 15703, 2016
强制性开放获取政策： Cancer Research UK
RETRACTED ARTICLE: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer
J Patterson-Fortin, H Jadhav, C Pantelidou, T Phan, C Grochala, ...
Nature Communications 14 (1), 1390, 2023
强制性开放获取政策： US National Institutes of Health, Doris Duke Charitable Foundation
STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer
C Pantelidou, H Jadhav, A Kothari, R Liu, GM Wulf, JL Guerriero, ...
NPJ Breast Cancer 8 (1), 102, 2022
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定